Specifically, VDAC1 was found to be substantially over-expressed by 6.2-fold in PBMCs from CLL patients, as compared with healthy donors (Fig 3Aa and 3B). This evidence concerns the gene VDAC1 and B-cell chronic lymphocytic leukemia.